A carregar...
Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma
OBJECTIVE: This prospective, observational, postmarketing surveillance was conducted to evaluate the safety and effectiveness of mogamulizumab, an anti‐CC chemokine receptor 4 (CCR4) monoclonal antibody, in patients with CCR4‐positive, relapsed or refractory (r/r) adult T‐cell leukemia‐lymphoma (ATL...
Na minha lista:
| Publicado no: | Eur J Haematol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850465/ https://ncbi.nlm.nih.gov/pubmed/30740787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13220 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|